DE3209149A1 - Verfahren zur gemeinsamen immunologischen bestimmung von prokollagen-peptid (typ iii) und prokollagen-peptid col 1 (typ iii) und verfahren zur herstellung von anti-prokollagen-peptid col 1 (typ iii)-serum - Google Patents

Verfahren zur gemeinsamen immunologischen bestimmung von prokollagen-peptid (typ iii) und prokollagen-peptid col 1 (typ iii) und verfahren zur herstellung von anti-prokollagen-peptid col 1 (typ iii)-serum

Info

Publication number
DE3209149A1
DE3209149A1 DE19823209149 DE3209149A DE3209149A1 DE 3209149 A1 DE3209149 A1 DE 3209149A1 DE 19823209149 DE19823209149 DE 19823209149 DE 3209149 A DE3209149 A DE 3209149A DE 3209149 A1 DE3209149 A1 DE 3209149A1
Authority
DE
Germany
Prior art keywords
type iii
procollagen peptide
coi
procollagen
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19823209149
Other languages
German (de)
English (en)
Inventor
Dietrich Dr Brocks
Horst Dr Neubauer
Helmut Dr Strecker
Rupert Dr Timpl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Original Assignee
Hoechst AG
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG, Max Planck Gesellschaft zur Foerderung der Wissenschaften eV filed Critical Hoechst AG
Priority to DE19823209149 priority Critical patent/DE3209149A1/de
Priority to AT83102338T priority patent/ATE55489T1/de
Priority to DE8383102338T priority patent/DE3381781D1/de
Priority to EP83102338A priority patent/EP0089008B1/de
Priority to US06/474,457 priority patent/US4504587A/en
Priority to JP58039299A priority patent/JPS58168961A/ja
Publication of DE3209149A1 publication Critical patent/DE3209149A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/819—Multifunctional antigen or antibody
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/824—Immunological separation techniques

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE19823209149 1982-03-13 1982-03-13 Verfahren zur gemeinsamen immunologischen bestimmung von prokollagen-peptid (typ iii) und prokollagen-peptid col 1 (typ iii) und verfahren zur herstellung von anti-prokollagen-peptid col 1 (typ iii)-serum Withdrawn DE3209149A1 (de)

Priority Applications (6)

Application Number Priority Date Filing Date Title
DE19823209149 DE3209149A1 (de) 1982-03-13 1982-03-13 Verfahren zur gemeinsamen immunologischen bestimmung von prokollagen-peptid (typ iii) und prokollagen-peptid col 1 (typ iii) und verfahren zur herstellung von anti-prokollagen-peptid col 1 (typ iii)-serum
AT83102338T ATE55489T1 (de) 1982-03-13 1983-03-10 Hochspezifisches antiserum gegen prokollagenpeptid col 1 (typ iii) und prokollagen-peptid (typ iii), seine herstellung und verwendung.
DE8383102338T DE3381781D1 (de) 1982-03-13 1983-03-10 Hochspezifisches antiserum gegen prokollagen-peptid col 1 (typ iii) und prokollagen-peptid (typ iii), seine herstellung und verwendung.
EP83102338A EP0089008B1 (de) 1982-03-13 1983-03-10 Hochspezifisches Antiserum gegen Prokollagen-Peptid Col 1 (Typ III) und Prokollagen-Peptid (Typ III), seine Herstellung und Verwendung.
US06/474,457 US4504587A (en) 1982-03-13 1983-03-11 Procedure for immunologic determination of procollagen peptide (type III) and procollagen peptide col 1 (type III) together and a process for preparing anti-procollagen peptide col 1 (type III) serum
JP58039299A JPS58168961A (ja) 1982-03-13 1983-03-11 プロコラーゲン―ペプチド類の測定法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823209149 DE3209149A1 (de) 1982-03-13 1982-03-13 Verfahren zur gemeinsamen immunologischen bestimmung von prokollagen-peptid (typ iii) und prokollagen-peptid col 1 (typ iii) und verfahren zur herstellung von anti-prokollagen-peptid col 1 (typ iii)-serum

Publications (1)

Publication Number Publication Date
DE3209149A1 true DE3209149A1 (de) 1983-10-06

Family

ID=6158138

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19823209149 Withdrawn DE3209149A1 (de) 1982-03-13 1982-03-13 Verfahren zur gemeinsamen immunologischen bestimmung von prokollagen-peptid (typ iii) und prokollagen-peptid col 1 (typ iii) und verfahren zur herstellung von anti-prokollagen-peptid col 1 (typ iii)-serum
DE8383102338T Expired - Fee Related DE3381781D1 (de) 1982-03-13 1983-03-10 Hochspezifisches antiserum gegen prokollagen-peptid col 1 (typ iii) und prokollagen-peptid (typ iii), seine herstellung und verwendung.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE8383102338T Expired - Fee Related DE3381781D1 (de) 1982-03-13 1983-03-10 Hochspezifisches antiserum gegen prokollagen-peptid col 1 (typ iii) und prokollagen-peptid (typ iii), seine herstellung und verwendung.

Country Status (5)

Country Link
US (1) US4504587A (ru)
EP (1) EP0089008B1 (ru)
JP (1) JPS58168961A (ru)
AT (1) ATE55489T1 (ru)
DE (2) DE3209149A1 (ru)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3209149A1 (de) * 1982-03-13 1983-10-06 Hoechst Ag Verfahren zur gemeinsamen immunologischen bestimmung von prokollagen-peptid (typ iii) und prokollagen-peptid col 1 (typ iii) und verfahren zur herstellung von anti-prokollagen-peptid col 1 (typ iii)-serum
US4628027A (en) * 1982-05-19 1986-12-09 Molecular Engineering Associates, Ltd. Vitro diagnostic methods using monoclonal antibodies against connective tissue proteins
DE3331627A1 (de) * 1983-09-01 1985-03-21 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verfahren zur immunologischen bestimmung fuer proteine in koerperfluessigkeiten, unter verwendung monovalenter antikoerperfragmente
SE8304836D0 (sv) * 1983-09-09 1983-09-09 Pharmacia Ab Sett att bestemma forendringar i ledbrosk
US5030576A (en) * 1986-04-30 1991-07-09 Genentech, Inc. Receptors for efficient determination of ligands and their antagonists or agonists
US4859609A (en) * 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US5316914A (en) * 1986-09-04 1994-05-31 Fuji Yakuhin Kogyo Kabushiki Kaisha Method for determining human collagen peptides by way of enzyme immunoassay
US5679583A (en) * 1987-05-02 1997-10-21 Hoechst Aktiengesellschaft Monoclonal antibodies for the selective immunological determination of intact procollagen peptide (type III) and procollagen (type III) in body fluids
DE3714634A1 (de) * 1987-05-02 1988-11-17 Hoechst Ag Verfahren zur selektiven immunologischen bestimmung von intaktem prokollagen peptid (typ iii) und prokollagen (typ iii) in koerperfluessigkeiten und mittel zu dessen durchfuehrung
ATE89862T1 (de) * 1987-05-02 1993-06-15 Hoechst Ag Monoklonaler antikoerper zur selektiven immunologischen bestimmung von intaktem prokollagen peptid (typ iii) und prokollagen (typ iii) in koerperfluessigkeiten.
GB2208865B (en) * 1987-08-19 1991-12-11 Farmos Group Ltd Purified propeptide of procollagen type iii, antibody to the propeptide and assay method using the antibody.
US5962639A (en) * 1987-11-06 1999-10-05 Washington Research Foundation Synthetic peptides corresponding to telopeptide sequences of cross-linked type I collagen metabolites
US6153732A (en) * 1987-11-06 2000-11-28 Washington Research Foundation Kit for detecting analyte indicative of type II collagen resorption in vivo
US4973666A (en) 1987-11-06 1990-11-27 Washington Research Foundation Peptide fragments containing HP and LP cross-links
US6027903A (en) * 1987-11-06 2000-02-22 Washington Research Foundation Kit for detecting analyte indicative of type I collagen resorption in vivo
US5300434A (en) * 1987-11-06 1994-04-05 Washington Research Foundation Hybridoma cell line producing an antibody to type-I collagen amino-terminal telopeptide
US5320970A (en) * 1987-11-06 1994-06-14 Washington Research Foundation Detection of collagen degradation in vivo
US5702909A (en) * 1987-11-06 1997-12-30 Washington Research Foundation Methods of detecting collagen type II degradation in vivo
US6010862A (en) * 1987-11-06 2000-01-04 Washington Research Foundation Methods of detecting collagen type III degradation in vivo
ES2065350T3 (es) * 1988-04-27 1995-02-16 Hoechst Ag Anticuerpo monoclonal para la determinacion immunologica selectiva de peptido (tipo iii) intacto y procolageno (tipo iii) en liquidos corporales.
US5541295A (en) * 1993-02-12 1996-07-30 The Board Of Governors For Higher Education State Of Rhode Island And Providence Plantations Detection of type II collagen and its peptides
DK104093D0 (da) * 1993-09-17 1993-09-17 Osteometer A S Fremgangsmaade til bestemmelse af collagen-fragmenter i legemsvaesker, test-kit og midler til udoevelse af fremgangsmaaden og anvendelse af fremgangsmaaden til diagnosticering af lidelser associeret til collagen-metabolismen
US6110689A (en) * 1994-01-21 2000-08-29 Osteometer A/S Method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen
GB9506050D0 (en) 1995-03-24 1995-05-10 Osteometer A S Assaying collagen fragments in body fluids
EP0787301B1 (en) 1994-10-17 2001-02-14 Osteometer Biotech AS Estimation of the fragmentation pattern of collagen in body fluids and the diagnosis of disorders associated with the metabolism of collagen
US6107047A (en) * 1996-03-21 2000-08-22 Osteometer Biotech A/S Assaying protein fragments in body fluids
GB9617616D0 (en) 1996-08-22 1996-10-02 Osteometer Biotech As Assaying protein fragments in body fluids
EP0944833B1 (en) 1996-12-09 2001-06-27 Osteometer Biotech AS Sandwich assays for collagen fragments
US6117646A (en) * 1997-09-22 2000-09-12 Osteometer Biotech A/S Assaying protein fragments in body fluids
DK1086135T3 (da) * 1998-05-28 2004-06-21 Bayer Healthcare Ag Monoklonalt antistof og assay til detektering af N-terminalt prokollagen (III)-propeptid (PIIINP)
US6602980B1 (en) 1998-06-19 2003-08-05 Washington Research Foundation Collagen type III synthetic peptides for collagen resorption assays
US6916903B2 (en) 1998-06-19 2005-07-12 Washington Research Foundation Collagen type III synthetic peptides for collagen resorption assays
US20120058948A1 (en) * 2006-10-16 2012-03-08 Stultz Collin M Collagen peptides as immune modulators
WO2009091581A2 (en) * 2008-01-18 2009-07-23 Vatrix Medical, Inc. Diagnostic biomarkers for vascular aneurysm

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2816841A1 (de) * 1978-04-18 1979-10-31 Max Planck Gesellschaft Radioimmunologische bestimmung von prokollagen (typ iii) und prokollagen- peptid (typ iii)
DE3209149A1 (de) * 1982-03-13 1983-10-06 Hoechst Ag Verfahren zur gemeinsamen immunologischen bestimmung von prokollagen-peptid (typ iii) und prokollagen-peptid col 1 (typ iii) und verfahren zur herstellung von anti-prokollagen-peptid col 1 (typ iii)-serum

Also Published As

Publication number Publication date
ATE55489T1 (de) 1990-08-15
US4504587A (en) 1985-03-12
EP0089008A2 (de) 1983-09-21
JPS58168961A (ja) 1983-10-05
DE3381781D1 (de) 1990-09-13
EP0089008B1 (de) 1990-08-08
EP0089008A3 (en) 1986-02-12
JPH0588421B2 (ru) 1993-12-22

Similar Documents

Publication Publication Date Title
EP0089008B1 (de) Hochspezifisches Antiserum gegen Prokollagen-Peptid Col 1 (Typ III) und Prokollagen-Peptid (Typ III), seine Herstellung und Verwendung.
DE69420556T2 (de) Assay für troponin i aus dem herzmuskel
EP0004940B1 (de) Verfahren zur radioimmunologischen Bestimmung von Prokollagen (Typ III) und Prokollagen-Peptid (Typ III), zur Herstellung von für das Verfahren geeignetem Prokollagen-Peptid (Typ III) und zur Herstellung von Anti-Prokollagen-Peptid (Typ III)-Serum
DE3854194T2 (de) Monoklonale antikörper gegen glykosyliertes albumin, hybride zellinien, die diese antikörper produzieren, sowie deren verwendung.
EP0073514B1 (de) Creatinin-Antikörper
EP0944832B1 (de) ANTIGENSPEZIFISCHER IgM-NACHWEIS
DE19649390A1 (de) Antigenspezifischer IgG-Nachweis
DE2923583A1 (de) Verfahren zur immunologischen bestimmung von basalmembranmaterial und hierfuer geeignete neue basalmembranfragmente
DE69119656T2 (de) Satz zur spezifischen Bestimmung von Angiotensin-II
EP0460190B1 (de) Verfahren zum nachweis von malignen erkrankungen
DE69108554T2 (de) Analyse der varianten von analyten.
DE69132122T2 (de) Reinigung von cytokeratinfragmenten
DE69033511T2 (de) Verfahren zum Nachweis von Knochen- und anderen Bindegewebeerkrankungen in Menschen und Tieren
EP0780687A2 (de) Verfahren zur Herstellung eines synthetischen Kalibrators für Sandwich-Immunoassays
DE3050311C2 (de) Verfahren zur herstellung fester Tr{ger f}r Prote ine zu analytischen Zwecken
DE19920704C1 (de) Verwendung eines gegen Harn-Trypsin-Inhibitors gerichteten Antikörpers für die Diagnose des Ausbruchs von AIDS
DE69733957T2 (de) Verfahren zur bestimmung der gegenwart des gehirnspezifischen proteins s-100 beta
EP0339443A2 (de) Monoklonaler Antikörper zur selektiven immunologischen Bestimmung von intaktem Prokollagen Peptid (Typ III) und Prokollagen (Typ III) in Körperflüssigkeiten
DE68927283T2 (de) HCG-Peptide zur Verwendung in Antikörper-Reinigungsverfahren
DE3686766T2 (de) Monoklonaler antikoerper gegen glutathion s-transferase und dessen verwendung zur diagnose von krebs.
DE19811196C2 (de) Verwendung von Anti-Creatinin-Antikörpern oder anderen Creatinin bindenden Substanz en zur Bestimmung von Creatinin in physiologischen Flüssigkeiten und Verfahren zu ihrer Herstellung
DE19505266C1 (de) Verwendung von polyklonalen humanen anti-hTg-Autoantikörpern als Reagenz für die klinische Diagnostik von Schilddrüsen-Autoimmunerkrankungen sowie Reagenziensatz für eine Bestimmung von anti-hTg-Autoantikörpern in Patientenseren
DE68922846T2 (de) Enzymimmuntest für menschliches typiv-collagen gemäss dem sandwichverfahren.
DE3854834T2 (de) Immuntest unter Verwendung von Antigenen, produziert in heterologen Organismen
DE69127255T2 (de) Verfahren zur Messung von menschlichem C-Peptid

Legal Events

Date Code Title Description
8141 Disposal/no request for examination